How cancer treatment affects normal cells
Part of Cancer clinical trials.
This study looks at how cancer therapies may change healthy cells in your body over time. By collecting samples before and during treatment, researchers hope to understand long-term effects of therapy on normal tissues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are about to start a systemic cancer treatment (like chemotherapy, targeted therapy, or immunotherapy) at a participating hospital
- You can provide urine, blood, and a cheek swab twice during the study
- You are expected to complete at least 3 months of treatment
- You do not have hepatitis B, hepatitis C, or HIV
- You can understand English well enough to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic changes that occur naturally in human tissues. If you are already scheduled for surgery or a procedure like a biopsy or endoscopy, researchers may ask for a small tissue sample to study how our cells can change over time.
This study is looking at DNA changes (mutations) in healthy people and in people who may have DNA damage from things like the sun, smoking, past diseases, or treatments like radiation. The goal is to better understand how these changes happen and what they mean.
This trial uses already collected liver tissue samples from adults to study how cells change over time in chronic liver disease. It could help researchers understand the disease better and find new ways to treat it.
This study collects blood (and other biospecimens) to look for immune and molecular markers that may help explain cancer risk or response to treatment. If you’re an adult whose provider thinks you could develop cancer, or who has confirmed/suspected cancer, you may be asked for samples and consent to help researchers.
This study collects information about how cancer care affects daily life, treatment side effects, and quality of life, and it stores imaging and related data for future research. You might be able to take part if you’re scheduled for treatment at the center (or you’re a healthy volunteer) and can complete the questionnaires.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
Hear when a new Somatic Mutation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.